Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Dialysis-Induced Hypotension by Inhibiting Plasma Kallikrein

NCT05297786 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT05297786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05297786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Dialysis-Induced Hypotension by Inhibiting Plasma Kallikrein
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
July 27, 2022
Completion date
September 26, 2024
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis complication, hypotension of hemodialysis